Amarex logo

Two Late Stage CNS Trials Initiated

Germantown, MD, USA (October 04, 2016) – Amarex Clinical Research has initiated two late stage clinical trials in relation to Central Nervous System (CNS) indications. Amarex will be providing the full CRO services to conduct these trials in Schizophrenia in adults, which will be carried out across North America, Europe and Asia. The product under development has the potential to be a breakthrough drug for the indications under investigation.

The initiation of these trials is a testament to Amarex’s growth and capabilities to handle late stage trials, especially those of an international nature. Amarex will bring its broad experience in the CNS field to bear on these trials to bring them to fruition.

Amarex’s CEO, Kazem Kazempour said: “The clinical evidence indicates that these drugs has the potential to provide substantial improvement of a clinically significant endpoint over available therapies.”

Schizophrenia is a chronic and severe disorder that affects how a person thinks, feels, and acts. Although schizophrenia is not as common as other mental disorders, it can be very disabling. Approximately 7 or 8 individuals out of 1,000 will have schizophrenia in their lifetime.

About Amarex Clinical Research

Amarex is a global, full service Contract Research Organization (CRO), whose leadership team has significant expertise conducting biomedical research, and whose combined experience includes the design and conduct of several hundred clinical research projects in many therapeutic indications. Amarex provides comprehensive services in Project Management (Phase I-IV, BE/BA, PK/PD), Regulatory Affairs, FDA Applications and Submissions, Applications and Submissions to international Health Authorities, GxP Compliance Audits, Clinical Operations, Adaptive Study Designs, Statistical Analysis, Data Management and General Consulting. Amarex has taken clients’ products through the entire approval process from writing the initial product approval strategy to the marketing approval application with a growing list of approved products. Amarex is committed to cost effective, high quality clinical product development.

Amarex Contact:
Patrick J. Burke
Business Development
patrickb@amarexcro.com

20201 Century Blvd., Fourth Floor
Germantown, MD 20874 USA
301 528 7000
www.amarexus.com

Contact Us

Book a meeting or send us a message to talk to one of our experts.